In recent years it has been demonstrated that neurocognitive impairment in HIV infection correlates with levels of markers of mononuclear phagocyte activation, in particular, levels of soluble CD14 (sCD14) and soluble CD163 (sCD163) [12–17]. The gene discussed is CD163; the disease is HIV infectious disease.